Literature DB >> 16651808

[Pharmacokinetic, pharmacological, and clinical profile of miglitol (SEIBULE), a novel alpha-glucosidase inhibitor].

Noboru Kuboyama1, Ichiro Hayashi, Tadashi Yamaguchi.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16651808     DOI: 10.1254/fpj.127.223

Source DB:  PubMed          Journal:  Nihon Yakurigaku Zasshi        ISSN: 0015-5691


× No keyword cloud information.
  2 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of the novel SGLT2 inhibitor ipragliflozin.

Authors:  Takeshi Kadokura; Wenhui Zhang; Walter Krauwinkel; Stefanie Leeflang; James Keirns; Yuta Taniuchi; Ikumi Nakajo; Ronald Smulders
Journal:  Clin Pharmacokinet       Date:  2014-11       Impact factor: 6.447

2.  Determination of the transient period of the EIS complex and investigation of the suppression of blood glucose levels by L-arabinose in healthy adults.

Authors:  Kiyoshi Shibanuma; Yoko Degawa; Koichi Houda
Journal:  Eur J Nutr       Date:  2010-12-17       Impact factor: 5.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.